How did Venn’s expertise and collaboration empower a small pharmaceutical company to overcome these challenges and breathe new life into a six-decade-old small molecule drug? In an ambitious endeavour, a small sized pharmaceutical company aimed to repurpose a small molecule drug that has been available for approximately six decades. Venn staff was involved in the project from 2007, which was temporarily halted in 2012. In 2021, the venture was revived in collaboration with Venn.
